“ The advocacy for affordable medicines is increasingly data-driven. Pharmacies and collectives are now using sales data to demonstrate to pharmaceutical companies the vast, untapped market for generics, encouraging more production and better distribution. They are creating maps of "medicine deserts"—areas where certain essential drugs are perpetually unavailable or unaffordable—and working with NGOs and government to address these gaps. This turns anecdotal evidence of struggle into actionable intelligence for policymakers. By moving the conversation from charity to market logic and public health strategy, these advocates are building a more sustainable foundation for affordability. They are proving that ethical business and universal access are not mutually exclusive, but are in fact the only sustainable path forward. -- https://genieknows.in/ ”